SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-19-028360
Filing Date
2019-09-13
Accepted
2019-09-13 21:06:36
Documents
1
Period of Report
2019-09-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4946
  Complete submission text file 0001127602-19-028360.txt   6654
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O WATSON PHARMACEUTICALS INC 311 BONNIE CIRCLE CORONA CA 92880
Business Address
PAPA JOSEPH C (Reporting) CIK: 0001242215 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 191093561